0000105770-19-000048.txt : 20191121 0000105770-19-000048.hdr.sgml : 20191121 20191121170425 ACCESSION NUMBER: 0000105770-19-000048 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20191119 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20191121 DATE AS OF CHANGE: 20191121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 191237989 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 8-K 1 form8kdepartureofoffic.htm 8-K Document
false0000105770 0000105770 2019-11-19 2019-11-19


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) – November 19, 2019
form8k111919.jpg
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
 
 
 
 
 
 
 
Pennsylvania
 
1-8036
 
23-1210010
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
 
 
 
 
 
 
530 Herman O. West Drive,
Exton,
PA
 
 
 
19341-0645
(Address of principal executive offices)
 
 
 
(Zip Code)
 Registrant’s telephone number, including area code: 610-594-2900
Not Applicable
(Former name or address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, par value $0.25 per share
WST
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

1


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 19, 2019, Ms. Karen Flynn, Senior Vice President and Chief Commercial Officer, informed Mr. Eric Green, President and Chief Executive Officer of West Pharmaceutical Services, Inc. (the “Company”), of her intention to step down from her role and retire as of December 31, 2019.  In connection with Ms. Flynn’s retirement, Ms. Cindy Reiss-Clark has been promoted to Senior Vice President of Global Market Units and Commercial Solutions from her previous role of Vice President and General Manager of the Company’s Biologics Market Unit, and Mr. Christopher Ryan has been promoted to Senior Vice President of Commercial Products and Emerging Markets from his previous role of Vice President and General Manager of the Company’s Generics Market Unit.

Ms. Flynn’s decision to retire was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.



2





SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



 
WEST PHARMACEUTICAL SERVICES, INC.
 
 
 
 
 
/s/ George L. Miller
 
George L. Miller
 
Senior Vice President, General Counsel and Corporate Secretary
 
 
 
 
November 21, 2019
 




3
 EX-101.SCH 2 wst-20191119.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Document and Entity Information Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 wst-20191119_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 wst-20191119_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 wst-20191119_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document and Entity Information [Abstract] -- None. No documentation exists for this element. -- Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag EX-101.PRE 6 wst-20191119_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 form8k111919.jpg GRAPHIC begin 644 form8k111919.jpg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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information Document and Entity Information
Nov. 19, 2019
Document and Entity Information [Abstract]  
Entity Central Index Key 0000105770
Document Type 8-K
Document Period End Date Nov. 19, 2019
Entity Registrant Name WEST PHARMACEUTICAL SERVICES, INC.
Entity Incorporation, State or Country Code PA
Entity File Number 1-8036
Entity Tax Identification Number 23-1210010
Entity Address, Address Line One 530 Herman O. West Drive,
Entity Address, City or Town Exton,
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19341-0645
City Area Code 610
Local Phone Number 594-2900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.25 per share
Trading Symbol WST
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 1 97 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Document and Entity Information Document and Entity Information Sheet http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation Document and Entity Information Document and Entity Information Cover 1 false false All Reports Book All Reports form8kdepartureofoffic.htm wst-20191119.xsd wst-20191119_cal.xml wst-20191119_def.xml wst-20191119_lab.xml wst-20191119_pre.xml form8k111919.jpg http://xbrl.sec.gov/dei/2019-01-31 true true JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8kdepartureofoffic.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "wst-20191119_cal.xml" ] }, "definitionLink": { "local": [ "wst-20191119_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "form8kdepartureofoffic.htm" ] }, "labelLink": { "local": [ "wst-20191119_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "wst-20191119_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "wst-20191119.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "wst", "nsuri": "http://www.westpharma.com/20191119", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "form8kdepartureofoffic.htm", "contextRef": "D2019Q4SD19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Document and Entity Information Document and Entity Information", "role": "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation", "shortName": "Document and Entity Information Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "form8kdepartureofoffic.htm", "contextRef": "D2019Q4SD19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "wst_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "-- None. No documentation exists for this element. --", "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.westpharma.com/20191119", "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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form8kdepartureofoffic_htm.xml IDEA: XBRL DOCUMENT 0000105770 2019-11-19 2019-11-19 false 0000105770 8-K 2019-11-19 WEST PHARMACEUTICAL SERVICES, INC. PA 1-8036 23-1210010 530 Herman O. West Drive, Exton, PA 19341-0645 610 594-2900 false false false false Common Stock, par value $0.25 per share WST NYSE false ZIP 15 0000105770-19-000048-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000105770-19-000048-xbrl.zip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end XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; }